MILAN ( – BOMI ITALIA, founded in 1985 and listed on the AIM Italia market since June 2015 at an IPO price of € 2.75 is the holding company of the Bomi Group, a leading international player providing a wide range of strategic logistics services for the medical devices sector. The group has a strong international presence with 69% of revenues generated abroad and activities in 20 countries, especially in Europe and Latin America. With over 30 years of history and 1,235 employees, Bomi serves more than 100 multinationals producing medical devices through 4 business units: storage, transportation, value-added solutions and hospital logistics. The group ended 2017 with 118 million euros in revenues, up 17% compared to 2016; in the last 13 years, organic growth amounted to around 10% (CAGR 2005-2017); EBITDA margin rose to 9.6% and group net profit to 2.1 million euro. According to IR Top Research estimates, the Bomi Group is expected to close 2018 with revenues of € 129.8 million, EBITDA of € 13.2 million (EBITDA margin of 10.2%), a Group net profit of 3.8 million and a net financial debt down to 23 million. The stock, which capitalizes around 52 million euros with an Enterprise Value of 78 million, has a multiple EV / EBITDA 2018 of 5.7x against an average value of 12.2 than the considered international peers.